• ANP as a Translational Lever in Cardiovascular Research

  2026-09-03

  A mechanistic and strategic guide to using rat Atrial Natriuretic Peptide in cardiovascular, renal, and metabolic research while preserving a critical distinction between ANP and adiponectin. The article translates findings from an aged-rat neuroinflammation study into better controls, identity documentation, and target-engagement strategies for ANP workflows.

• HCN4 Heat Sensing and Heart Rate Control

  2026-09-02

  The 2025 Nature Communications study identifies an M407/Y409 motif in the HCN4 S4–S5 linker as a molecular determinant of heat-sensitive pacemaker current and heart-rate acceleration. By combining computational modeling, mutagenesis, cellular electrophysiology, isolated-heart experiments, and CRISPR/Cas9 mice, the authors show that this motif links thermal sensing to both HCN4 heat responses and cAMP-dependent gating.

• Cy3 NHS ester (non-sulfonated): Protocol Guide

  2026-09-02

  Cy3 NHS ester (non-sulfonated), SKU A8100, provides an amine-reactive orange fluorophore for labeling soluble proteins, peptides, oligonucleotides, and DNA. It is appropriate when the workflow can tolerate a DMSO or DMF co-solvent, but its water insolubility makes a sulfonated Cy3 NHS ester a better choice for especially delicate or co-solvent-sensitive biomolecules.

• Anti Reverse Cap Analog for mRNA Translation

  2026-09-01

  Learn how Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, supports more consistent synthetic mRNA expression in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide explains practical design, optimization, interpretation, and vendor-selection considerations for SKU B8175.

• Redox Intelligence in Hypoxic Tumor Microenvironments

  2026-09-01

  Hypoxia and nutrient competition reshape tumor and immune-cell metabolism, but the resulting redox phenotype is often under-measured. This thought-leadership guide shows how paired GSH and GSSG measurements can strengthen mechanism-focused studies, improve experimental decisions, and support more disciplined translational biomarker development.

• Chemotherapy and Neoantigen Presentation in T Cell Therapy

  2026-08-31

  Sagie et al. identify the KRAS.G12V-specific TCR T104 and show that lymphodepleting chemotherapy enhances neoantigen-directed tumor killing by increasing immunoproteasome activity, HLA-I expression, and peptide presentation. The study provides a mechanistic framework for interpreting chemotherapy as an active modifier of tumor immune visibility rather than only as a conditioning treatment.

• Reversine (A3760): Aurora Kinase Workflow Guide

  2026-08-31

  Reversine is an Aurora kinase inhibitor for controlled investigation of mitotic regulation, cell-cycle disruption, cancer cell proliferation inhibition, and apoptosis-related phenotypes. This guide explains how to prepare and quality-check the compound while distinguishing product-dossier potency values from workflow recommendations; it is not a clinical-use or disease-treatment protocol.

• Masitinib (AB1010): KIT/PDGFR Workflow Guide

  2026-08-30

  Masitinib (AB1010), SKU A2942, provides a DMSO-compatible tool for studying KIT, PDGFRα, and PDGFRβ inhibition in cancer, mast-cell, and inflammatory research. It is unsuitable for aqueous or ethanol-based workflows and should not be treated as a universal kinase inhibitor or as a direct substitute for a paper-matched protocol.

• IAM-LC vs LEKC for Pulmonary Permeability

  2026-08-29

  This 2024 Journal of Chromatography A study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for biomimetic drug partitioning and pulmonary permeability assessment. LEKC more closely reflected apparent lung permeability, whereas IAM-LC offered broader compound coverage, simpler implementation, and stronger suitability for high-throughput screening.

• GRK Control of Biased M1 Receptor Signaling

  2026-08-28

  A 2025 study used quantitative BRET assays to show that GRK subtype behavior helps determine how the M1 muscarinic receptor engages G proteins and β-arrestin 2. Its analysis of BQCA further indicates that this allosteric modulator can activate M1-associated protein interactions alone and increase acetylcholine sensitivity across both signaling systems.

• EPZ-6438: Selective EZH2 Inhibitor Guide

  2026-08-28

  EPZ-6438 is a selective EZH2 inhibitor that blocks SAM-dependent PRC2 methyltransferase activity and reduces H3K27me3. Its nanomolar biochemical activity and activity in SMARCB1-deficient, EZH2-mutant lymphoma, and HPV-associated cancer models support its use in epigenetic cancer research.

• CLCC1 and Herpesvirus Nuclear Egress: Study Insights

  2026-08-27

  The reference preprint identifies the host factor CLCC1 as essential for membrane fusion during herpesvirus nuclear egress, distinguishing this poorly understood step from viral capsid envelopment. Its CRISPR-screen and cell-biological findings connect herpesvirus release with nuclear pore complex insertion and suggest an evolutionarily conserved membrane-remodeling mechanism.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-08-27

  The 2024 Development study links SMPD4-dependent ceramide production to primary cilium formation and brain development across mouse and human cellular models. Its rescue experiments provide a mechanistic framework for understanding why SMPD4 variants cause microcephaly, cerebellar hypoplasia, and neural progenitor defects.

• Tetrandrine: From Ion Channels to Assay Design

  2026-08-26

  Tetrandrine is a versatile Tetrandrine alkaloid for calcium-channel, inflammation, neuroscience, and cancer biology research. This assay-first guide connects its physicochemical properties with rigorous workflow design and explains how natural-product screening evidence should shape—not overstate—mechanistic conclusions.

• Atrial Natriuretic Peptide: Rat Workflow Guide

  2026-08-26

  Build reproducible rat cardiovascular experiments around Atrial Natriuretic Peptide, from solution preparation through renal, vascular, and adipose readouts. The workflow also shows how causal-control logic from a neuroinflammation study can strengthen ANP study design without confusing adiponectin biology with ANP activity.

7901 records 1/527 page Next 12345 下5页 Last page